BARCELONA, October 12, 2023 Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems, has announced that the European Patent Office has granted the company a European patent for "A Device and a Thrombectomy Apparatus for Extraction of Thrombus from a Blood Vessel," published as Patent No. EP3866708 B1 on September 27, 2023. In addition, the US 11,771,446 B2 was also granted to the company on October 3, 2023, for a method to improve the efficacy of remov
Anaconda Biomed S L : Anaconda Biomed Announces Additional Granted Patents for its Innovative Thrombectomy Device for Ischemic Stroke Treatment finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Penumbra (NYSE:PEN – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products primarily addresses neuro […]
Penumbra (NYSE:PEN – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Wednesday, Zacks.com reports. According to Zacks, “Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company’s portfolio of products primarily addresses […]